Gadolinium-based Contrast Agent Global Analysis & Forecast to 2024 Gadolinium-based Contrast Agent Market - Global In

Gadolinium-based Contrast Agent Market -
Global Industry Analysis, Size, Share, Growth,
Trends, and Forecast 2016 - 2024
Gadolinium (Gd) is found as a rare earth metal, which is tough to extract, and it
appears like a silvery white crystal. It is one of the few metals with ferromagnetic
properties at room temperature. Like most of the rare earth metals, gadolinium
forms trivalent ions with fluorescent properties. Gadolinium is used for shielding in
neutron radiography and in nuclear reactor as it absorbs neutrons. Therefore,
applications of the metal are seen in oven, microwave, and other electronic
components. In medical field, it is utilized merely in the form of solution composites
for radiological images enhancement. The gadolinium ions that occur in water
soluble salts are toxic to human. But chelated Gd compounds are less toxic to
human body as they are filtered out of the kidneys before the free ions get released
into the tissue. This property of Gd increases its use in the medical field, where it is
used as intravenous drug in diagnostic imaging procedures to enhance the quality
of magnetic resonance angiography (MRA) or magnetic resonance imaging (MRI).
The global gadolinium-based contrast agent market is a fairly matured market and
is expected to witness a significant growth in the near future. The growth of the
market is likely to be driven during the forecast period by the rising prevalence of
chronic diseases such as cardiac diseases and cancer.
Report Detail @
http://www.transparencymarketresearch.com/gadolinium-based-contrast-agent-
market.html
The global gadolinium-based contrast agent market is segmented on the basis of
contrast agent type, disease indication, end-user, and geography. On the basis of
contrast agent type, the market is divided into linear non-ionic agent, linear ionic,
macrocyclic non-ionic, and macrocyclic ionic. The rates of dissociation of Gd from
macrocyclic ligands are slower than the dissociation from linear ligands. Higher the
dissociation constant, there is more possibility of de-chelating and release of free
Gd ions into the body which may lead to serious adverse events. Therefore, linear
gadolinium-based contrast agents are widely preferred for MRI scans.
On the basis of disease indication, the market is segmented into cardiovascular
disorders, neurological disorders, respiratory diseases, nephrological disorders, and